Obagi Medical
$130.00 · Eye cream
Your profile match
Community
Not enough reports yet (0/3).
Ideal for
Not recommended for
Caution
May aggravate: Seborrheic Dermatitis (Ethylhexyl Palmitate, Glyceryl Stearate, Stearyl Alcohol and Cetyl Alcohol); Atopic Dermatitis / Eczema (Propylene Glycol); Rosacea (Propylene Glycol)
Set up a profile to see which of these apply to you.
Obagi's ELASTIderm Eye Cream is a firming formula that strengthens skin by encouraging the production of collagen and elastin. The advanced blend of
After cleansing skin, gently apply small dots of the ELASTIderm eye treatment around eye area, including lid, under-eye and corner creases. Smooth in until thoroughly absorbed. Avoid getting into eyes. For best results, apply twice daily, in the morning and at night.
Key actives
Water, Ethylhexyl Palmitate, C13-15 Alkane, Glycerin, Glyceryl Stearate, Cyclopentasiloxane, C12-15 Alkyl Benzoate, Peg-100 Stearate, Diproprylene Glycol Dibenzoate, Propylene Glycol, Dimethicone, Stearyl Alcohol, PPG-15 Stearyl Ether Benzoate, Polyacrylamide, Cetyl Alcohol, Cetyl Dimethicone, C13-14 Isoparaffin, Xanthan Gum, Magnesium Aluminum Silicate, Laureth-7, Tocopheryl Acetate (Vitamin E Acetate), Glycyrrhiza Glabra (Licorice) Root Extract, Algae Extract, Vaccinium Angustifolium (Blueberry) Fruit Extract, Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben, Isobutylparaben, HDI/Trimethylol Hexyllactone Crosspolymer, Sodium Hydroxide, Malonic Acid, Malachite, Zinc Carbonate, Silica, Talc, Alumina, Titanium Dioxide (CI 77891), Mica (CI 77019), Iron Oxides (CI 77491). For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption.
79 studies on 26of this product’s ingredients. These study the ingredient, not this product.
Annals of Internal Medicine, 2013 · n=903 · rct
Daily application of SPF 15+ broad-spectrum sunscreen reduced clinical skin aging by 24% (OR 0.76, 95% CI 0.59–0.98) over 4.5 years compared with discretionary use in the Nambour randomized trial; microtopography confirmed significantly less photoaging progression; Australian NHMRC-funded with no industry involvement
Journal of Cosmetic Dermatology, 2025 · systematic-review
Updated review covering 67 articles: tinted sunscreen formulations containing iron oxides achieve visible light attenuation rates exceeding 93%, compared to <10% for non-tinted formulations; confirms iron oxides as the only practical approach to visible light photoprotection in topical sunscreens; recommends tinted sunscreens as standard of care for melasma and PIH-prone patients
Journal of Clinical and Aesthetic Dermatology, 2020 · systematic-review
Review of photoprotection for melasma: tinted mineral sunscreens containing iron oxides + titanium dioxide provide broad-spectrum protection including visible light (380-740 nm), which is a critical melasma trigger; chemical-only sunscreens are insufficient for melasma patients; recommends mineral-tinted SPF 30+ as standard of care for melasma management
Used this product? Sign in to share your outcome and see what people with your skin reported.
Sign in to add your experienceNo reports yet. Be the first to share your experience.
Community outcomes are self-reported member experiences, shown separately from the evidence score — never blended into it. Educational, not medical advice.